| 000 | 01784 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250511181744.0 | ||
| 264 | 0 | _c19920204 | |
| 008 | 199202s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19920115)69:2<396::aid-cncr2820690220>3.0.co;2-e _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBassan, R | |
| 245 | 0 | 0 |
_aAcute undifferentiated leukemia with CD7+ and CD13+ immunophenotype. Lack of molecular lineage commitment and association with poor prognostic features. _h[electronic resource] |
| 260 |
_bCancer _cJan 1992 |
||
| 300 |
_a396-404 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntigens, CD _xanalysis |
| 650 | 0 | 4 | _aAntigens, CD7 |
| 650 | 0 | 4 |
_aAntigens, Differentiation _xanalysis |
| 650 | 0 | 4 |
_aAntigens, Differentiation, Myelomonocytic _xanalysis |
| 650 | 0 | 4 |
_aAntigens, Differentiation, T-Lymphocyte _xanalysis |
| 650 | 0 | 4 | _aCD13 Antigens |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 |
_aLeukemia _xclassification |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNucleotide Mapping |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProto-Oncogene Mas |
| 650 | 0 | 4 |
_aRNA, Neoplasm _xanalysis |
| 700 | 1 | _aBiondi, A | |
| 700 | 1 | _aBenvestito, S | |
| 700 | 1 | _aTini, M L | |
| 700 | 1 | _aAbbate, M | |
| 700 | 1 | _aViero, P | |
| 700 | 1 | _aBarbui, T | |
| 700 | 1 | _aRambaldi, A | |
| 773 | 0 |
_tCancer _gvol. 69 _gno. 2 _gp. 396-404 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19920115)69:2<396::aid-cncr2820690220>3.0.co;2-e _zAvailable from publisher's website |
| 999 |
_c1376705 _d1376705 |
||